Pascal and Francis Bibliographic Databases

Help

Search results

Your search

au.\*:("TANAKA, Shigebumi")

Publication Year[py]

A-Z Z-A Frequency ↓ Frequency ↑
Export in CSV

Discipline (document) [di]

A-Z Z-A Frequency ↓ Frequency ↑
Export in CSV

Results 1 to 8 of 8

  • Page / 1
Export

Selection :

  • and

Expression of Foxp3 in non-small cell lung cancer patients is significantly higher in tumor tissues than in normal tissues, especially in tumors smaller than 30 mmISHIBASHI, Yasunori; TANAKA, Shigebumi; TAJIMA, Kohei et al.Oncology reports. 2006, Vol 15, Num 5, pp 1315-1319, issn 1021-335X, 5 p.Article

Fluorine -18-α-Methyltyrosine Positron Emission Tomography for Diagnosis and Staging of Lung Cancer : A Clinicopathologic StudyKAIRA, Kyoichi; ORIUCHI, Noboru; DOBASHI, Kunio et al.Clinical cancer research. 2007, Vol 13, Num 21, pp 6369-6378, issn 1078-0432, 10 p.Article

Pulmonary function after pulmonary resection by posterior thoracotomy, anterior thoracotomy or video-assisted surgeryENDOH, Hideki; TANAKA, Shigebumi; YAJIMA, Toshiki et al.European journal of cardio-thoracic surgery. 2010, Vol 37, Num 5, pp 1209-1214, issn 1010-7940, 6 p.Article

L-type amino acid transporter 1 and CD98 expression in primary and metastatic sites of human neoplasmsKAIRA, Kyoichi; ORIUCHI, Noboru; ENDOU, Hitoshi et al.Cancer science. 2008, Vol 99, Num 12, pp 2380-2386, issn 1347-9032, 7 p.Article

CDX2 as a useful marker of colorectal adenocarcinoma metastases to lung in pre-operative biopsy specimensTANAKA, Shigebumi; SAITO, Kana; ITO, Tomokazu et al.Oncology reports. 2007, Vol 18, Num 1, pp 87-92, issn 1021-335X, 6 p.Article

Immunohistochemical analysis of phosphorylated epidermal growth factor receptor might provide a surrogate marker of EGFR mutationENDOH, Hideki; ISHIBASHI, Yasunori; KUWANO, Hiroyuki et al.Lung cancer. 2009, Vol 63, Num 2, pp 241-246, issn 0169-5002, 6 p.Article

Thymoma with ganglioneuroblastomatous component : case reportKASHIWABARA, Kenji; IKOTA, Hayato; TANAKA, Shigebumi et al.Virchows Archiv. 2008, Vol 452, Num 3, pp 319-324, issn 0945-6317, 6 p.Article

Phase ii prospective study of the efficacy of gefitinib for the treatment of stage III/IV non-small cell lung cancer with EGFR mutations, irrespective of previous chemotherapySUNAGA, Noriaki; TOMIZAWA, Yoshio; SAITO, Ryusei et al.Lung cancer. 2007, Vol 56, Num 3, pp 383-389, issn 0169-5002, 7 p.Article

  • Page / 1